Ophthalmology
Eyes & vision clinical trials
Eye disease and conditions that affect sight. We’re tracking 1,816 recruiting studies in this area right now.
By phase
- Not applicable1,252
- Phase 3131
- Phase 2121
- Phase 1120
- Phase 491
- Phase 1/Phase 285
- Phase 2/Phase 316
Top conditions
- Glaucoma108
- Cataract90
- Myopia89
- Diabetic Retinopathy53
- Dry Eye42
- Keratoconus34
- Age-Related Macular Degeneration33
- Retinitis Pigmentosa31
- Sjogren's Syndrome29
- Diabetic Macular Edema26
- Eye Diseases26
- Graves Disease26
- Amblyopia24
- Astigmatism23
- Dry Eye Disease (DED)23
- Multiple Sclerosis23
- Retinal Disease23
- Macular Degeneration22
Leading sponsors
- Zhongshan Ophthalmic Center, Sun Yat-sen University28
- Second Affiliated Hospital, School of Medicine, Zhejiang University23
- Medical University of Vienna19
- Fondation Ophtalmologique Adolphe de Rothschild18
- National Taiwan University Hospital17
- Assistance Publique - Hôpitaux de Paris16
- Eye & ENT Hospital of Fudan University15
- National Eye Institute (NEI)15
- Shanghai Eye Disease Prevention and Treatment Center15
- Duke University13
Where studies are running
- California143
- Arizona66
- Texas41
- Maryland39
- New York34
- Massachusetts33
- Florida32
- Alabama27
- North Carolina21
- Pennsylvania21
Recruiting studies1,816 total
- NCT07282691Recruiting
Validating eye tests for mild brain injury
This study looks at eye tests for people who had a mild brain injury (mTBI) in the last 1 to 6 months. It aims to better understand and measure eye movement problems that can happen after such an injury.
Philadelphia, PennsylvaniaAges 18–35 - NCT07284797RecruitingPhase 1
Safety study for autoimmune disease and healthy volunteers
This trial is testing an experimental drug for safety in people with certain autoimmune diseases—like myositis, scleroderma, or Sjögren's disease—as well as in healthy volunteers. It aims to find out if the drug is safe enough to study further.
MelbourneAges 18–75 - NCT07284966Recruiting
Comfort and vision with TOTAL30 multifocal lenses
This trial tests how comfortable and clear your vision is with TOTAL30 multifocal contact lenses. If you already wear multifocal soft lenses and are 40+, you may qualify to help understand how these lenses perform in daily life.
San Diego, CaliforniaAges 40 years+ - NCT07286656RecruitingPhase 1
A study of GensSci098 for Graves' disease
This study tests a new investigational drug called GensSci098 for people with Graves' disease who have not taken antithyroid medication recently. It aims to see if the drug can help manage thyroid hormone levels.
Shenyang, LiaoningAges 18 years+ - NCT07290244RecruitingPhase 1
Testing ER-100 safety for glaucoma or NAION patients
This trial tests whether a new drug, ER-100, is safe for people with glaucoma or a sudden optic nerve injury called NAION. It aims to see if the drug can be given without serious side effects.
Glendale, CaliforniaAges 40–85 - NCT07291687Recruiting
Test of tDCS for improving walking
This study tests whether a safe, non-invasive brain stimulation (tDCS) can improve movement and walking in people who have trouble with motor function. You can join if you're able to walk daily, with or without a walking aid, and don't have metal in your brain.
Toronto, OntarioAges Any age - NCT07292987Recruiting
Support program for people newly diagnosed with retinitis pigmentosa
This study is testing a new way to support people who have just been told they have retinitis pigmentosa (RP) at the Quinze-Vingts hospital in Paris. It aims to help you understand your diagnosis and get the care you need.
Paris, Île-de-France RegionAges 18–65 - NCT07294716Recruiting
New lens for cataract patients with irregular corneas
This trial tests a special type of lens implant (asymmetric toric intraocular lens) for people having cataract surgery who also have an irregularly shaped cornea. The goal is to see if this lens can improve the quality of your vision after surgery.
LinzAges 21 years+ - NCT07295691Recruiting
Autologous serum eye drops for dry eye
This trial tests whether eye drops made from your own blood can help treat moderate to severe dry eye that hasn't improved with artificial tears.
CairoAges Up to 18 years - NCT07296952Recruiting
Improving transportation for diabetic retinopathy patients
This study tests a new way to help people with diabetic retinopathy get to their eye appointments. It aims to make transportation easier for patients who have Medicaid insurance.
Chicago, IllinoisAges 18 years+ - NCT07297849Recruiting
Eyelid closure effect on cornea measurement
This trial tests whether closing the eyelids changes the accuracy of a cornea measurement tool. It may help people whose cornea measurements are flagged as "warning" by the device.
Vienna, State of ViennaAges 18 years+ - NCT07298356Recruiting
Updated eye pressure measurement in routine exams
This study tests an updated device that measures eye pressure during a routine eye exam. It is for adults who are already coming in for a check-up and have no eye infections or scarring.
Durham, North CarolinaAges 18 years+ - NCT07298811RecruitingPhase 1/Phase 2
Healthy eye bacteria for dry eye treatment
This study tests whether putting healthy bacteria from a family member's eye surface onto your eyes can help treat moderate to severe dry eye. You would receive standard dry eye drops plus the experimental transplant.
Nanchang, JiangxiAges 18–70 - NCT07298824RecruitingPhase 2
Study of MR-61 to slow nearsightedness in children and teens
This trial tests if MR-61 can help slow down the progression of myopia (nearsightedness) in children and teenagers. It may be an option for patients between 3 and 18 years old who are already nearsighted and have no other eye problems.
Nanchang, JiangxiAges 3–18 - NCT07301892Recruiting
AI help for rheumatoid arthritis diagnosis
This trial tests whether artificial intelligence (AI) can improve how doctors spot complications in people newly diagnosed with rheumatoid arthritis (RA), a condition that causes joint pain and swelling. The goal is to see if AI can make diagnosis faster and more accurate in real-world hospital settings.
Beijing, Beijing MunicipalityAges Any age - NCT07303257Recruiting
Quality of life after glaucoma surgery: a patient-centered study
This study compares how different types of glaucoma surgery affect your daily life and well-being. If you need glaucoma surgery, you may join to help doctors understand which procedure works best from a patient's perspective.
LyonAges 18 years+ - NCT07303296RecruitingPhase 2
Gene therapy study for vision loss from LHON
This trial tests a gene therapy called GS010 given as an injection into the eye for people with vision loss from LHON. It aims to see if it can help improve vision in both eyes.
ParisAges 15 years+ - NCT07303920Recruiting
Comfort of daily disposable contacts for astigmatism over a long day
This study tests how comfortable daily disposable contact lenses for astigmatism feel when worn for a long day (like 16 hours). It may help you find a lens that stays comfortable and clear from morning to night.
Columbus, OhioAges 18–40 - NCT07308639Recruiting
Eye disease health data study in Germany
This study looks at health records in Germany to understand how many people have certain eye conditions like age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. It also tests new ways to use this information for research.
LeverkusenAges 18 years+ - NCT07310719Recruiting
Comparing laser versus eye drops for new glaucoma patients
This trial compares two first treatments—laser therapy (SLT) or daily eye drops (latanoprost)—to lower eye pressure in people newly diagnosed with open-angle glaucoma or high eye pressure. It aims to find which approach works better as an initial therapy.
Ikeja, LagosAges 18–90 - NCT07312214Recruiting
Red light therapy for slowing vision loss in severe nearsightedness
This trial tests if daily low-level red light can protect the back of the eye in people with severe nearsightedness. It aims to slow damage that leads to vision loss.
ShanghaiAges 18–55 - NCT07313618RecruitingEarly Phase 1
Gene therapy for children with oculocutaneous albinism type 1
This trial tests a single injection of JWK010 gene therapy for children aged 5 to 12 with OCA1A albinism. The therapy is given into the eye to try to improve vision, and is meant for those who have not had gene therapy before.
Chengdu, SichuanAges 5–12 - NCT07318961Recruiting
Using a piece of your own eye tissue to fix a stubborn macular hole
This trial tests whether a small piece of tissue from your own eye (the Tenon's capsule) can be used as a patch to help close a macular hole that hasn't healed with previous surgery or is chronic and large.
Banhā, BenhaAges 18 years+ - NCT07321756Recruiting
Presbyopia-correcting lens implants for complex cataracts
This study tests special lenses (IOLs) that aim to correct presbyopia (trouble seeing up close) in people with complex cataracts or other eye conditions. It may help if you have a lens that is partially out of place, long-term eye inflammation, a cataract after laser eye surgery, or if you are missing a lens and need a new one.
Hangzhou, ZhejiangAges 18–80
Common questions
- How many eyes & vision clinical trials are recruiting?
- Clin2 is tracking 1,816 recruiting ophthalmology studies from the U.S. registry right now, out of 2,924 we cover in this area in total.
- What does “Eyes & vision” cover here?
- Eye disease and conditions that affect sight. We group each study into eyes & vision based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a eyes & vision trial near me?
- Use the search to filter eyes & vision studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.